Mingang Hao

2.5k total citations · 1 hit paper
32 papers, 1.8k citations indexed

About

Mingang Hao is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Mingang Hao has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Oncology and 9 papers in Immunology. Recurrent topics in Mingang Hao's work include Chemokine receptors and signaling (7 papers), Autophagy in Disease and Therapy (6 papers) and Epigenetics and DNA Methylation (5 papers). Mingang Hao is often cited by papers focused on Chemokine receptors and signaling (7 papers), Autophagy in Disease and Therapy (6 papers) and Epigenetics and DNA Methylation (5 papers). Mingang Hao collaborates with scholars based in China, United States and Australia. Mingang Hao's co-authors include Xueqing Sun, Guangcun Cheng, Jianghua Zheng, Xiaoming Zhou, Jianhua Wang, Jun‐Lin Guan, Russell S. Taichman, Kenneth J. Pienta, Jian Zhang and Syn Kok Yeo and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Biomaterials.

In The Last Decade

Mingang Hao

31 papers receiving 1.8k citations

Hit Papers

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression 2010 2026 2015 2020 2010 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingang Hao China 22 877 804 496 398 180 32 1.8k
Rosaria Gangemi Italy 25 1.1k 1.3× 760 0.9× 485 1.0× 391 1.0× 164 0.9× 52 2.2k
Ping‐Pui Wong China 18 1.1k 1.3× 479 0.6× 360 0.7× 751 1.9× 155 0.9× 29 1.8k
Yi Fan United States 27 1.3k 1.5× 674 0.8× 516 1.0× 629 1.6× 240 1.3× 64 2.4k
Douglas W. McMillin United States 25 1.2k 1.4× 837 1.0× 329 0.7× 263 0.7× 138 0.8× 57 2.1k
Qian Zhan United States 21 948 1.1× 729 0.9× 260 0.5× 262 0.7× 155 0.9× 36 1.6k
Olivier Cabaud France 11 908 1.0× 817 1.0× 310 0.6× 553 1.4× 314 1.7× 19 1.7k
Susan Mason United Kingdom 17 1.4k 1.6× 648 0.8× 356 0.7× 673 1.7× 189 1.1× 33 2.1k
Dana A. M. Mustafa Netherlands 20 589 0.7× 476 0.6× 401 0.8× 339 0.9× 263 1.5× 84 1.4k
Ryan M. Young United States 19 976 1.1× 809 1.0× 741 1.5× 312 0.8× 124 0.7× 36 2.6k
Antonella Zannetti Italy 27 1.1k 1.2× 669 0.8× 240 0.5× 426 1.1× 177 1.0× 66 2.0k

Countries citing papers authored by Mingang Hao

Since Specialization
Citations

This map shows the geographic impact of Mingang Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingang Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingang Hao more than expected).

Fields of papers citing papers by Mingang Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingang Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingang Hao. The network helps show where Mingang Hao may publish in the future.

Co-authorship network of co-authors of Mingang Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Mingang Hao. A scholar is included among the top collaborators of Mingang Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingang Hao. Mingang Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Qiu, Kangqiang, Weiwei Zou, Hongbao Fang, et al.. (2022). Light-activated mitochondrial fission through optogenetic control of mitochondria-lysosome contacts. Nature Communications. 13(1). 4303–4303. 37 indexed citations
4.
Wu, Tianqi, Wenfeng Wang, Guohai Shi, et al.. (2022). Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression. Cell Death and Disease. 13(7). 624–624. 38 indexed citations
5.
Yang, Yongguang, Zhenhua Luo, Syn Kok Yeo, et al.. (2021). Functional cooperation between co-amplified genes promotes aggressive phenotypes of HER2-positive breast cancer. Cell Reports. 34(10). 108822–108822. 18 indexed citations
6.
Fang, Hongbao, Shanshan Geng, Mingang Hao, et al.. (2021). Simultaneous Zn2+ tracking in multiple organelles using super-resolution morphology-correlated organelle identification in living cells. Nature Communications. 12(1). 109–109. 94 indexed citations
8.
Wu, Hsin‐Jung, Mingang Hao, Syn Kok Yeo, & Jun‐Lin Guan. (2020). FAK signaling in cancer-associated fibroblasts promotes breast cancer cell migration and metastasis by exosomal miRNAs-mediated intercellular communication. Oncogene. 39(12). 2539–2549. 133 indexed citations
9.
Yeo, Syn Kok, Xiaoting Zhu, Takako Okamoto, et al.. (2020). Single-cell RNA-sequencing reveals distinct patterns of cell state heterogeneity in mouse models of breast cancer. eLife. 9. 42 indexed citations
10.
Chen, Qixin, Xintian Shao, Mingang Hao, et al.. (2020). Quantitative analysis of interactive behavior of mitochondria and lysosomes using structured illumination microscopy. Biomaterials. 250. 120059–120059. 83 indexed citations
11.
Sun, Xueqing, Qing Qu, Yimin Lao, et al.. (2019). Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer. BMC Cancer. 19(1). 1180–1180. 22 indexed citations
12.
Hao, Mingang, Jinglong Wang, Jun Qin, et al.. (2017). HIC1 loss promotes prostate cancer metastasis by triggering epithelial–mesenchymal transition. The Journal of Pathology. 242(4). 409–420. 23 indexed citations
13.
Hao, Mingang, Xiaoling Weng, Yingying Wang, et al.. (2017). Targeting CXCR7 improves the efficacy of breast cancer patients with tamoxifen therapy. Biochemical Pharmacology. 147. 128–140. 19 indexed citations
14.
Zu, Lidong, Yunjing Xue, Jinglong Wang, et al.. (2016). The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasis. Carcinogenesis. 37(3). 333–343. 52 indexed citations
15.
Cheng, Guangcun, Xuemei Fan, Mingang Hao, et al.. (2016). Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer. Molecular Cancer. 15(1). 30–30. 71 indexed citations
16.
Zheng, Jianghua, Jinglong Wang, Xueqing Sun, et al.. (2013). HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification. Clinical Cancer Research. 19(6). 1400–1410. 51 indexed citations
17.
Cheng, Guangcun, Xueqing Sun, Jinglong Wang, et al.. (2013). HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression through Misregulation of LCN2. Cancer Research. 74(3). 862–872. 50 indexed citations
18.
Chen, Xiaosong, Mingang Hao, Xueqing Sun, et al.. (2013). Dual Inhibition of PI3K and mTOR Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer. Molecular Cancer Research. 11(10). 1269–1278. 36 indexed citations
19.
Zheng, Jianghua, Dan Xiong, Xueqing Sun, et al.. (2012). Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression. Cancer Microenvironment. 5(3). 285–293. 25 indexed citations
20.
Sun, Xueqing, Guangcun Cheng, Mingang Hao, et al.. (2010). CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression. Cancer and Metastasis Reviews. 29(4). 709–722. 605 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026